Gregory Brooks Bass - Net Worth and Insider Trading

Gregory Brooks Bass Net Worth

The estimated net worth of Gregory Brooks Bass is at least $1,761 dollars as of 2024-11-13. Gregory Brooks Bass is the Chief Commercial Officer of Lipocine Inc and owns about 331 shares of Lipocine Inc (LPCN) stock worth over $1,761. Details can be seen in Gregory Brooks Bass's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Gregory Brooks Bass has not made any transactions after 2017-12-29 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Gregory Brooks Bass

To

Gregory Brooks Bass Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Gregory Brooks Bass owns 1 companies in total, including Lipocine Inc (LPCN) .

Click here to see the complete history of Gregory Brooks Bass’s form 4 insider trades.

Insider Ownership Summary of Gregory Brooks Bass

Ticker Comapny Transaction Date Type of Owner
LPCN Lipocine Inc 2017-12-29 EVP and Chief Commercial Offic

Gregory Brooks Bass Latest Holdings Summary

Gregory Brooks Bass currently owns a total of 1 stock. Gregory Brooks Bass owns 331 shares of Lipocine Inc (LPCN) as of December 29, 2017, with a value of $1,761.

Latest Holdings of Gregory Brooks Bass

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
LPCN Lipocine Inc 2017-12-29 331 5.32 1,761

Holding Weightings of Gregory Brooks Bass


Gregory Brooks Bass Form 4 Trading Tracker

According to the SEC Form 4 filings, Gregory Brooks Bass has made a total of 0 transactions in Lipocine Inc (LPCN) over the past 5 years. The most-recent trade in Lipocine Inc is the sale of 221 shares on December 29, 2017, which brought Gregory Brooks Bass around $13,013.

Insider Trading History of Gregory Brooks Bass

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Gregory Brooks Bass Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Gregory Brooks Bass Ownership Network

Ownership Network List of Gregory Brooks Bass

No Data

Ownership Network Relation of Gregory Brooks Bass

Insider Network Chart

Gregory Brooks Bass Owned Company Details

What does Lipocine Inc do?

Who are the key executives at Lipocine Inc?

Gregory Brooks Bass is the EVP and Chief Commercial Offic of Lipocine Inc. Other key executives at Lipocine Inc include director & President and CEO Mahesh V. Patel , Chief Medical Officer George Nomikos , and Principal Accounting Officer Krista Fogarty .

Lipocine Inc (LPCN) Insider Trades Summary

Over the past 18 months, Gregory Brooks Bass made no insider transaction in Lipocine Inc (LPCN). Other recent insider transactions involving Lipocine Inc (LPCN) include a net purchase of 8,706 shares made by Mahesh V. Patel ,

In summary, during the past 3 months, insiders sold 0 shares of Lipocine Inc (LPCN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Lipocine Inc (LPCN) were sold and 8,706 shares were bought by its insiders, resulting in a net purchase of 8,706 shares.

Lipocine Inc (LPCN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Lipocine Inc Insider Transactions

No Available Data

Gregory Brooks Bass Mailing Address

Above is the net worth, insider trading, and ownership report for Gregory Brooks Bass. You might contact Gregory Brooks Bass via mailing address: 3228 Brookside Drive, Furlong Pa 18925.